![Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e7d31c91-9c6a-4ecc-87eb-2074454af216/gr1a.jpg)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
![Barriers and enablers to locally-led clinical trial conduct in low and middle income countries: strategies for developing locally sustainable health research capacity | Semantic Scholar Barriers and enablers to locally-led clinical trial conduct in low and middle income countries: strategies for developing locally sustainable health research capacity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ec1534bbc006aeea448ab131cad2c156db06d6f2/27-Table2-1-1.png)
Barriers and enablers to locally-led clinical trial conduct in low and middle income countries: strategies for developing locally sustainable health research capacity | Semantic Scholar
![CISCRP's 2019 Perceptions and Insights Study - Center for Information & Study on Clinical Research Participation CISCRP's 2019 Perceptions and Insights Study - Center for Information & Study on Clinical Research Participation](https://www.ciscrp.org/wp-content/uploads/2019/09/P-I-Chart-1024x576.png)
CISCRP's 2019 Perceptions and Insights Study - Center for Information & Study on Clinical Research Participation
![Ongoing Clinical Trials for the Management of the COVID-19 Pandemic: Trends in Pharmacological Sciences Ongoing Clinical Trials for the Management of the COVID-19 Pandemic: Trends in Pharmacological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8e9a80c5-3e9a-4f55-9f5e-4d0638d176a9/gr1_lrg.jpg)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic: Trends in Pharmacological Sciences
![Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/168739/f/1.png)
Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
![Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meeting – topic of research paper in Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meeting – topic of research paper in](https://cyberleninka.org/viewer_images/1320817/f/1.png)